Blood test could personalize lung cancer care, avoid unnecessary chemo
NCT ID NCT04166487
First seen Nov 01, 2025 · Last updated May 17, 2026 · Updated 21 times
Summary
This study tests whether a blood test taken during treatment can show if immunotherapy (pembrolizumab) is working well enough alone, or if adding chemotherapy is needed. About 40 people with stage IV non-small cell lung cancer will give blood samples at different times. The goal is to use this information to tailor treatment and improve outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC NON-SMALL CELL LUNG CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Boston Medical Center
Boston, Massachusetts, 02118, United States
-
Brigham and Women's Hospital
Boston, Massachusetts, 02115, United States
-
Dana Farber Cancer Institute
Boston, Massachusetts, 02115, United States
-
Dana-Farber at Steward St. Elizabeth's Medical Center
Brighton, Massachusetts, 02135, United States
-
Dana-Farber/Brigham and Women's Cancer Center (DF/BWCC) in clinical affiliation with South Shore Hospital
South Weymouth, Massachusetts, 02190, United States
Conditions
Explore the condition pages connected to this study.